T1D Patient Achieves Full Insulin Independence After Stem Cell Transplant But clinical trial currently under FDA hold as dosing is discussed Jun 06, 2022
Tirzepatide Reduced Albuminuria in T2D Patients With Heart Risk Subanalysis of SURPASS-4 trial compared the GLP-1/GIP agonist against insulin glargine Jun 06, 2022
Can Longstanding BP Meds Protect Against Brain Aneurysm Ruptures? RAAS inhibitors could be therapy of choice for those with hypertension and intracranial aneurysms Jun 06, 2022
Is Diabetes a Risk Factor for Long COVID? Possibly. Mixed results in seven-study scoping review Jun 05, 2022
Dulaglutide Improves HbA1c for Youth With Type 2 Diabetes Safety profile consistent with that reported in adults Jun 05, 2022
Tirzepatide Serves Up Major Weight-Loss Win in Patients With Obesity SURMOUNT-1 trial tested GIP/GLP-1 receptor agonist in people without diabetes Jun 05, 2022
No Cardioprotection Seen With Long-Term Metformin or Lifestyle Intervention Both approaches "highly effective" in T2D, but not for preventing CV disease, expert says May 24, 2022
TAVR for Aortic Regurgitation Off to a Good Start in the Real World Yet some growing pains remain for the Jenavalve Trilogy May 21, 2022
No-Implant Shunt Eases HF Symptoms in Early Data Quality of life consistently improved across first-in-man studies May 20, 2022
TAVR Stays Its Course as 10-Year Durability Data Trickle In Glimpse of longer-term valve degeneration in early TAVR patients May 19, 2022
Renal Denervation Responders Hint at Good Clinical Outcomes A taste of clinical outcomes data when a randomized trial is unlikely May 17, 2022
Diabetic Pain Relief Lasts With High Frequency Spinal Cord Stimulation Trial followed patients with Senza System for 18 months May 16, 2022
Patients With Type 2 Diabetes and CKD Face Poor COVID Outcomes Severity of kidney disease ups risk of ICU time, in-hospital mortality, and more May 15, 2022
First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetes Injectable tirzepatide lands approval as an adjunct to diet and exercise May 13, 2022
Black Kids From Poorer Neighborhoods Hit Hardest by DKA Readmissions But even those in areas with better resources faced disparities versus other children May 05, 2022
How Often Does Prediabetes in Seniors Escalate to Full-Blown Disease? Study finds estimated annual progression rate to diabetes of 5.3% Apr 20, 2022
Who Is Really Driving Up Insulin Costs? More attention needs to focus on pharmaceutical middlemen Apr 18, 2022
In Type 2 Diabetes, Metabolic Control Could Add Years to Life Controlling four biomarkers could add as much as a decade to life expectancy Apr 18, 2022
Novel Agents Promising in Pruritus, Rare Metabolic Disease, and More A round-up of noteworthy research from the NKF Spring Clinical Meetings Apr 10, 2022
Novel Drug Cuts Proteinuria in APOL1-Mediated Kidney Disease Significant UPCR reductions in just a few weeks in phase II study Apr 10, 2022
Even With CKD, Patiromer Helped Heart Failure Patients Keep Hyperkalemia at Bay Promising findings from prespecified renal analysis of the DIAMOND trial Apr 09, 2022
Systemic Corticosteroids in Acute HF: Worth Another Look? Some see a potential treatment for patients with more inflammation Apr 08, 2022
Which Factors Predict Rapid Decline in Polycystic Kidney Disease? Researchers pinpointed six clinical variables predictive of rapid decline to ESRD Apr 08, 2022
Flu a Consistent Threat to ESRD Patients Those with advanced-stage kidney disease had 28% higher risk of in-hospital death Apr 08, 2022
The Winners and Losers of the Proposed Insulin Cost Cap While it benefits some, the $35 cap is only a stopgap measure Apr 08, 2022
COVID-Related AKI Chronically Hard on Kidneys More critically ill COVID patients developed CKD versus bacterial pneumonia patients Apr 08, 2022
Which Anticonvulsant Mood Stabilizer Upped Diabetes Risk? Observational study looked at 5-year risk differences between four agents Apr 06, 2022
Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HF Patients better able to achieve target dose of mineralocorticoids and angiotensin inhibitors Apr 04, 2022
EHR Pop-Ups Spur Better GDMT Implementation in Heart Failure Alert-based intervention in PROMPT-HF trial said to be low-cost, scalable Apr 03, 2022
Tide Turns on Withholding Blood Pressure Meds for Pregnant Women Antihypertensive treatment was safe for mothers and children in the CHAP trial Apr 02, 2022
Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Events Sodium restriction still holds its ground in SODIUM-HF trial Apr 02, 2022
From 'Pre-HF' to 'HFimpEF': Guidelines Redefine Heart Failure Stages, Classes Update also adds SGLT2 inhibitor as a pillar of therapy Apr 01, 2022
Pumping (IV) Iron Linked to Varying Anaphylaxis Risk for Older Adults Study finds risk was low, but unequal across different products Mar 28, 2022
GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder? Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug Mar 28, 2022
In HFpEF, Do MRA Users Get as Much Benefit From an SGLT2 Inhibitor? EMPEROR-Preserved trial weighs in Mar 21, 2022
Cost-Analysis Fuels Debate on Transplant Waitlists Without available kidneys, expense of longer lists not justified, researchers argue Mar 10, 2022
EHR 'Nudge' Linked to Fewer C. Diff Tests for Organ Transplant Recipients The program also led to fewer days of antibiotics and cost savings Mar 07, 2022
E-Cig Use Tied to Higher Odds of Prediabetes As in regular cigarettes, nicotine may play a role, researcher says Mar 03, 2022
ARB-Cancer Link May Come Down to Cumulative Exposure Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022
